Navigating Gender-Affirming Hormone Therapy in Autistic Transgender and Gender Diverse Adults: Challenges and Strategies for Optimal Adherence
Transgender HealthSensory processinggender-affirming hormone therapyautism spectrum disordertreatment adherence
Highlight
- Autistic transgender and gender diverse (TGD) adults report more challenges in adhering to gender-affirming hormone therapy (GAHT) compared to their non-autistic peers.
- Key barriers include sensory processing differences and executive functioning difficulties, affecting medication administration and tolerability.
- Successful adherence strategies involve developing consistent routines, integrating GAHT into personal care, leveraging peer support, and involving trusted individuals in care appointments.
- This evidence underscores the need for tailored clinical approaches in gender endocrinology to optimize GAHT outcomes among autistic TGD adults.
Study Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
